International Journal of Colorectal Disease

, Volume 22, Issue 5, pp 483–489

Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers

  • Shih-Ching Chang
  • Pei-Ching Lin
  • Jen-Kou Lin
  • Shung-Haur Yang
  • Huann-Sheng Wang
  • Anna Fen-Yau Li
Original Article

Abstract

Background and aims

By altering both DNA methylation and nucleotide synthesis, folate metabolism is thought to contribute to colorectal carcinogenesis. We examined the role of folate metabolism in three different phenotypes of sporadic colorectal cancers (CRCs), phenotypes that were classified by the status of microsatellite instability (MSI) and chromosomal instability (CIN): MSI-H, microsatellite stability (MSS)/aneuploidy, and MSS/diploid.

Patients and methods

A total of 195 sporadic colorectal tumors and another 195 age- and gender-matched healthy volunteers in Taipei-Veteran General Hospital and Taipei City Hospital were collected. We analyzed for MTHFR (methylenetetrahydrofolate reductase) polymorphisms (C677T, A1297C), folate, and vitamin B12 levels. We determined MSI status and DNA ploidy with fluorescent polymerase chain reaction and flow cytometry. Relations between clinicopathological variables and molecular variables were analyzed by χ2 tests (with Yates’ correction) for categorical variables and Student’s t test for numerical variables.

Results

Folate levels (5.02±4.43 ng/ml) were significantly lower in cancer patients than in controls (7.22±4.46 ng/ml). Vitamin B12 level was similar between cancer patients and controls. The frequency of the TT genotype of MTHFR C627T (12.3%) was slightly higher than controls (8.2%), but it did not reach statistical significance (p=0.174). Within the low-folate group (<5 ng/ml), the frequency of the TT genotype in cancer patients (14.4%) was significantly higher than in controls (4.6%). Sixteen patients who had MSI-H CRC (8.2%) had a significantly higher frequency of TT MTHFR (37.5%) and lower folate levels (3.56±2.41 ng/ml) than patients with MSS tumors (10.1%, 5.14±3.72 ng/ml). Patients with MSS/aneuploid tumors had significantly lower folate levels (4.50±3.06 ng/ml) than those with MSS/diploid tumors (6.69±4.73 ng/ml).

Conclusion

Folate deficiency and the MTHFR genetic polymorphism play an important role in colorectal carcinogenesis, including MSI and CI.

Synopsis

Folate metabolism plays an important role in colorectal carcinogenesis. We demonstrate that patients with MSI-H tumors had higher frequency of TT MTHFR C627T (37.5%), and patients with MSS/aneuploid tumor had lower folate level (4.50±3.06 ng/ml).

Keywords

MTHFR Folate Microsatellite instability Chromosomal instability Colorectal cancer 

Abbreviations

CEA

carcinoembryonic antigen

CIN

chromosomal instability

CRC

colorectal cancer

HNPCC

hereditary nonpolyposis colorectal cancer

MSI-H

high microsatellite instability

MSS

microsatellite stability

MTHFR

methylenetetrahydrofolate reductase

References

  1. 1.
    Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G (1999) Genomic changes defining the genesis, progression and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25:195–204PubMedCrossRefGoogle Scholar
  2. 2.
    Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in colorectal cancers. Nature 386:623–627PubMedCrossRefGoogle Scholar
  3. 3.
    Aaltonen LA, Salovaara R, Kristo P et al (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338:1481–1487PubMedCrossRefGoogle Scholar
  4. 4.
    Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, Thibodeau SN (1998) Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58:3455–3460PubMedGoogle Scholar
  5. 5.
    Chang SC, Lin JK, Yang SH, Wang HS, Li FY, Chi CW (2006) Relationship between genetic alterations and prognosis in sporadic colorectal cancer. Int J Cancer 118:1721–1727PubMedCrossRefGoogle Scholar
  6. 6.
    Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159–170PubMedCrossRefGoogle Scholar
  7. 7.
    Kim YI (1999) Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10:66–88PubMedCrossRefGoogle Scholar
  8. 8.
    Kim Y, Salamon R, Graeme-Cook F, Choi S, Smith D, Dallal G et al (1996) Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 39:732–742PubMedGoogle Scholar
  9. 9.
    Cravo M, Mason J, Dayal Y, Hutchinson M, Smith D, Selhub J et al (1992) Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res 5002–5006Google Scholar
  10. 10.
    Kane M, Loda M, Gaida G et al (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808–811PubMedGoogle Scholar
  11. 11.
    Shannon B, Gnanasampanthan S, Beilby J, Iacopetta B (2002) A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut 50:520–524PubMedCrossRefGoogle Scholar
  12. 12.
    Eaton AM, Sandler R, Carethers JM, Millikan RC, Galanko J, Keku TO (2005) 5,10-Methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer. Cancer Epidemiol Biomark Prev 14:2023–2029CrossRefGoogle Scholar
  13. 13.
    Li R, Sonik A, Stindl R, Rasnick D, Duesberg P (2000) Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci U S A 97:3236–3241PubMedCrossRefGoogle Scholar
  14. 14.
    James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW (1999) Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70:495–501PubMedGoogle Scholar
  15. 15.
    Fenech M (2001) The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat Res 475:57–67PubMedGoogle Scholar
  16. 16.
    Fenech M, Baghurst P, Luderer W, Turner J, Record S, Ceppi M, Bonassi S (2005) Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability—results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis 26:991–999PubMedCrossRefGoogle Scholar
  17. 17.
    Wang X, Thomas P, Xue J, Fenech M (2004) Folate deficiency induces aneuploidy in human lymphocytes in vitro-evidence using cytokinesis-blocked cells and probes specific for chromosomes 17 and 21. Mutat Res 551:167–180PubMedGoogle Scholar
  18. 18.
    Selhub J (2002) Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging 6:39–42PubMedGoogle Scholar
  19. 19.
    Hao L, Ma J, Stampfer MJ et al (2003) Geographical, seasonal and gender differences in folate status among Chinese adults. J Nutr 133:3630–3635PubMedGoogle Scholar
  20. 20.
    Sobin LH, Wittekind C (1997) UICC TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York, pp 66–69Google Scholar
  21. 21.
    Slattery M, Potter J, Samowitz W et al (1999) Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomark Prev 8:513–518Google Scholar
  22. 22.
    Kelemen LE, Anand SS, Hegele RA et al (2004) Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians. Atherosclerosis 176:361–370PubMedCrossRefGoogle Scholar
  23. 23.
    Hsu LA, Ko YL, Wang SM, Chang CJ, Hsu TS, Chiang CW, Lee YS (2001) The C677T mutation of the methylenetetrahydrofolate reductase gene is not associated with the risk of coronary artery disease or venous thrombosis among Chinese in Taiwan. Hum Hered 51:41–45PubMedCrossRefGoogle Scholar
  24. 24.
    Li M, Lau EM, Woo J (2004) Methylenetetrahydrofolate reductase polymorphism (MTHFR C677T) and bone mineral density in Chinese men and women. Bone 35:1369–1374PubMedCrossRefGoogle Scholar
  25. 25.
    Tang R, Changchien CR, Wu MC et al (2004) Colorectal cancer without high microsatellite instability and chromosomal instability—an alternative genetic pathway to human colorectal cancer. Carcinogenesis 25:841–846PubMedCrossRefGoogle Scholar
  26. 26.
    Ma J, Stampfer MJ, Christensen B et al (1999) A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocysteine, and colorectal cancer risk. Cancer Epidemiol Biomark Prev 8:825–829Google Scholar
  27. 27.
    Chen J, Stampfer MJ, Ma J, Selhub J, Malinow MR, Hennekens CH, Hunter DJ (2001) Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 154:667–672PubMedCrossRefGoogle Scholar
  28. 28.
    Ko JM, Cheung MH, Kwan MW, Wong CM, Lau KW, Tang CM, Lung ML (1999) Genomic instability and alterations in APC, MCC and DCC in Hong Kong patients with colorectal carcinoma. Int J Cancer 84:404–409PubMedCrossRefGoogle Scholar
  29. 29.
    Koinuma K, Shitoh K, Miyakura Y et al (2004) Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas. Int J Cancer 108:237–242PubMedCrossRefGoogle Scholar
  30. 30.
    Deng G, Bell I, Crawley S et al (2004) BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10:191–195PubMedCrossRefGoogle Scholar
  31. 31.
    Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954PubMedCrossRefGoogle Scholar
  32. 32.
    Choi SW, Mason JB (2002) Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 132:2413S–2418SPubMedGoogle Scholar
  33. 33.
    Blount BC, Ames BN (1995) DNA damage in folate deficiency. Bailliere’s Best Pract Res Clin Haematol 8:461–478Google Scholar
  34. 34.
    Blount BC, Mack MM, Wehr CM et al (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 94:3290–3295PubMedCrossRefGoogle Scholar
  35. 35.
    Ames BN (1999) Micronutrient deficiencies. A major cause of DNA damage. Ann N Y Acad Sci 889:87–106PubMedCrossRefGoogle Scholar
  36. 36.
    Duthie SJ, Narayanan S, Sharp L, Little J, Basten G, Powers H (2004) Folate, DNA stability and colo-rectal neoplasia. Proc Nutr Soc 63:571–578PubMedCrossRefGoogle Scholar
  37. 37.
    Jacques PF, Sulsky SI, Sadowski JA, Phillips JC et al (1993) Comparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient status. Am J Clin Nutr 57:182–189PubMedGoogle Scholar
  38. 38.
    Green TJ, Allen OB, O’Connor DL (1998) A three-day weighed food record and a semiquantitative food-frequency questionnaire are valid measures for assessing the folate and vitamin B-12 intakes of women aged 16 to 19 years. J Nutr 128:1665–1671PubMedGoogle Scholar
  39. 39.
    McKinley MC, Strain JJ, McPartlin J, Scott JM, McNulty H (2001) Plasma homocysteine is not subject to seasonal variation. Clin Chem 47:1430–1436PubMedGoogle Scholar
  40. 40.
    Melse-Boonstra A, de Bree A, Verhoef P, Bjorke-Monsen AL, Verschuren WM (2002) Dietary monoglutamate and polyglutamate folate are associated with plasma folate concentrations in Dutch men and women aged 20–65 years. J Nutr 132:1307–1312PubMedGoogle Scholar
  41. 41.
    Herbert V (1982) Experimental nutritional folate deficiency in man. Nutr Rev 40:246–248CrossRefGoogle Scholar
  42. 42.
    Drogan D, Klipstein-Grobusch K, Wans S, Luley C, Boeing H, Dierkes J (2004) Plasma folate as marker of folate status in epidemiological studies: the European Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Br J Nutr 92:489–496PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Shih-Ching Chang
    • 1
  • Pei-Ching Lin
    • 2
  • Jen-Kou Lin
    • 1
  • Shung-Haur Yang
    • 1
  • Huann-Sheng Wang
    • 1
  • Anna Fen-Yau Li
    • 3
  1. 1.Department of Surgery, Division of Colon & Rectal Surgery, Taipei Veterans General HospitalNational Yang-Ming UniversityTaipeiTaiwan
  2. 2.Department of Clinical Pathology, Ren-Ai BranchTaipei City HospitalTaipeiTaiwan
  3. 3.Department of Pathology, Taipei Veterans General HospitalNational Yang-Ming UniversityTaipeiTaiwan

Personalised recommendations